Search

Search Constraints

You searched for: Author/Creator Meijer, Chris J. L. M.

Search Results

1. Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high‐risk human papillomavirus‐positive population. (30th September 2022)

3. Characterisation of anal intraepithelial neoplasia and anal cancer in HIV‐positive men by immunohistochemical markers p16, Ki‐67, HPV‐E4 and DNA methylation markers. Issue 10 (4th August 2021)

4. Classification of high‐grade cervical intraepithelial neoplasia by p16ink4a, Ki‐67, HPV E4 and FAM19A4/miR124‐2 methylation status demonstrates considerable heterogeneity with potential consequences for management. Issue 3 (11th May 2021)

5. Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer. Issue 2 (28th July 2020)

6. Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine. Issue 7 (3rd July 2018)

7. Evaluation of FAM19A4/miR124‐2 methylation performance in the management of CIN3 diagnosed pregnant women. Issue 9 (20th June 2022)

8. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124‐2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions. (5th February 2020)

9. Focal aberrations indicate EYA2 and hsa‐miR‐375 as oncogene and tumor suppressor in cervical carcinogenesis12. Issue 1 (14th September 2012)

10. Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer. Issue 7 (3rd July 2018)